Paper42007477
Exploring the prognostic value of serum albumin in critically ill cancer patients: an observational cohort study utilizing machine learning from large intensive care unit databases.
Wang G and 11 others. JAMIA Open, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Exploring the prognostic value of serum albumin in critically ill cancer patients: an observational cohort study utilizing machine learning from large intensive care unit databases. Papers, record 42007477. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42007477
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Exploring the prognostic value of serum albumin in critically ill cancer patients: an observational cohort study utilizing machine learning from large intensive care unit databases.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15163774 | A comparison of albumin and saline for fluid resuscitation in the intensive care unit. | N Engl J Med | 2004 | https://conductscience.org/library/papers/15163774 | PubMed |
| 2 | 28561532 | Pretreatment albumin level predicts survival in head and neck squamous cell carcinoma. | Laryngoscope | 2017 | https://conductscience.org/library/papers/28561532 | PubMed |
| 3 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 4 | 37762957 | Serum Albumin Levels: A Biomarker to Be Repurposed in Different Disease Settings in Clinical Practice. | J Clin Med | 2023 | https://conductscience.org/library/papers/37762957 | PubMed |
| 5 | 19657486 | Recommendations for the use of albumin and immunoglobulins. | Blood Transfus | 2009 | https://conductscience.org/library/papers/19657486 | PubMed |
| 6 | 34006622 | Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes. | Neurol Neuroimmunol Neuroinflamm | 2021 | https://conductscience.org/library/papers/34006622 | PubMed |
| 7 | 16915107 | Albumin administration improves organ function in critically ill hypoalbuminemic patients: A prospective, randomized, controlled, pilot study. | Crit Care Med | 2006 | https://conductscience.org/library/papers/16915107 | PubMed |
| 8 | 2607039 | Validation of a severity of illness score (APACHE II) in a surgical intensive care unit. | Intensive Care Med | 1989 | https://conductscience.org/library/papers/2607039 | PubMed |
| 9 | 31356475 | Lactated Ringer's Versus 4% Albumin on Lactated Ringer's in Early Sepsis Therapy in Cancer Patients: A Pilot Single-Center Randomized Trial. | Crit Care Med | 2019 | https://conductscience.org/library/papers/31356475 | PubMed |
| 10 | 30288759 | Hypoalbuminemia: Pathogenesis and Clinical Significance. | JPEN J Parenter Enteral Nutr | 2019 | https://conductscience.org/library/papers/30288759 | PubMed |
| 11 | 27843637 | Critically ill patients with cancer: chances and limitations of intensive care medicine-a narrative review. | ESMO Open | 2016 | https://conductscience.org/library/papers/27843637 | PubMed |
| 12 | 38755213 | Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma. | Sci Rep | 2024 | https://conductscience.org/library/papers/38755213 | PubMed |
| 13 | 33657293 | A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis. | N Engl J Med | 2021 | https://conductscience.org/library/papers/33657293 | PubMed |
| 14 | 36596836 | MIMIC-IV, a freely accessible electronic health record dataset. | Sci Data | 2023 | https://conductscience.org/library/papers/36596836 | PubMed |
| 15 | 39757061 | Systemic metabolic crosstalk as driver of cancer cachexia. | Trends Endocrinol Metab | 2025 | https://conductscience.org/library/papers/39757061 | PubMed |
| 16 | 31143998 | Changes in critically ill cancer patients' short-term outcome over the last decades: results of systematic review with meta-analysis on individual data. | Intensive Care Med | 2019 | https://conductscience.org/library/papers/31143998 | PubMed |
| 17 | 25466337 | Mortality prediction in intensive care units with the Super ICU Learner Algorithm (SICULA): a population-based study. | Lancet Respir Med | 2015 | https://conductscience.org/library/papers/25466337 | PubMed |
| 18 | 33190763 | Triage and Prognostication of Cancer Patients Admitted to the Intensive Care Unit. | Crit Care Clin | 2021 | https://conductscience.org/library/papers/33190763 | PubMed |
| 19 | 34397592 | Expert consensus on the use of human serum albumin in critically ill patients. | Chin Med J (Engl) | 2021 | https://conductscience.org/library/papers/34397592 | PubMed |
| 20 | 29739107 | Low Serum Albumin Correlates with Poor Survival in Gastric Cancer Patients. | Clin Lab | 2018 | https://conductscience.org/library/papers/29739107 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42007477
GET https://conductscience.org/api/papers/v1/42007477/references?page=2